2013

Krečmerová M., Jansa P., Dračínský M., Sázelová P., Kašička V., Neyts J., Auwerx J., Kiss E., Goris N., Stepan G., Janeba Z.:
9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: Optimized preparation, including identification of by-products formed, and antiviral evalution in vitro.
Biooorg. Med. Chem. 2013, 21, 1199-1208.
 
Keough D. T., Špaček P., Hocková D., Tichý T., Vrbková S., Slavětínská L., Janeba Z., Naesens L., Edstein M. D., Chavchich M., Wang T-H., de Jersey J., Guddat L. W.:
J. Med. Chem. 2013, 56, 2513-2526.
 
Keough D. T., Hocková D., Rejman D., Špaček P., Vrbková S., Krečmerová M., Eng W. S., Jans H., West N. P.,  Naesens L. M. J., de Jersey J., Guddat L. W.:
J. Med. Chem. 2013, 56, 6967−6984.
 
Coen N., Duraffour S., Naesens L., Krečmerová M., Van den Oord J., Snoeck R., Andrei G.:
Evaluation of Novel Acyclic Nucleoside Phosphonates against Human and Animal Gammaherpesviruses Revealed an Altered Metabolism of Cyclic Prodrugs upon Epstein-Barr Virus Reactivation in P3HR-1 Cells.
J. Virol. 2013, 87, 12422-12432.